Avatar photo

Ron Finklestien

Challenges in New Home Construction Slump In Housing Starts: ‘Extremely Noisy’ Numbers Suggest Demand For New Homes Is Dipping

Amidst a cacophony of falling numbers, it has been revealed that the number of homebuilding projects initiated in January plummeted to the lowest rate ...

GOOGL January 2026 Options Trading Exploring the GOOGL January 2026 Options Trading Week

Alphabet Inc (Symbol: GOOGL) made waves as new options began trading for the January 2026 expiration this week. With 700 days until expiration, these ...

Applied Materials Inc. Surpasses Q1 Earnings Forecasts Despite Y/Y Sales Dip Applied Materials Inc. Surpasses Q1 Earnings Forecasts Despite Y/Y Sales Dip

Applied Materials Inc. (AMAT) reported first-quarter fiscal 2024 non-GAAP earnings of $2.13 per share, exceeding the Zacks Consensus Estimate by 12.1%. Moreover, the figure ...

Market Analysis: Friday Sector Laggards in Television & Radio, General Contractors & Builders Friday Market Analysis Unveils Laggards in Television & Radio, General Contractors & Builders

Television & radio shares experienced a drop of about 1.9% on Friday’s trading. Ondas Holdings witnessed a decrease of approximately 10.1% while Liberty Global ...

DXC Technology Advancements Amid Renewed Takeover Speculation DXC Technology’s Stock on the Move

Maksim Labkouski/iStock via Getty Images DXC Technology (NYSE:DXC) saw an impressive 1.4% surge on the back of renewed takeover speculation. Some industry sources are ...

Andersons (ANDE) Q4 Earnings Preview Andersons (ANDE) Q4 Earnings Preview: What to Anticipate

The Andersons (ANDE) is set to announce its fourth-quarter 2023 results after the closing bell on Feb 20. Q4 Estimates The Zacks Consensus Estimate ...

The Top 3 Hot Stocks Heating Up This February The Top 3 Hot Stocks Heating Up This February

Despite recent fluctuations and concerns, the future of the U.S. economy appears positive. Following the pre-Covid boom, the Covid-induced crash, and a too-hot recovery ...

Gilead Sciences Hit With Enrollment Pause – Stock Dips 2.22% Gilead Sciences Hit With Enrollment Pause – Stock Dips 2.22%

Biopharmaceutical giant Gilead Sciences Inc (NASDAQ: GILD) found its stock in a bind after announcing a pause in the enrollment of tumor studies. The ...

Dropbox (DBX) Topples Expectations with Q4 Earnings Surge Dropbox (DBX) Q4 Earnings Beat Estimates, Revenues Up Y/Y

Dropbox, Inc. (DBX) reported a victorious fourth-quarter 2023 with non-GAAP earnings of 50 cents per share, surpassing the Zacks Consensus Estimate by 4.17% and ...

BIDU Options: Analyzing Opportunities for Investors

As of today, a new set of options for the August 16th expiration have become available for investors in Baidu Inc (Symbol: BIDU). With ...